U.S. FDA advisory meetings through Jan 28

BLOOD PRODUCTS ADVISORY COMMITTEE

DATE: Dec. 14-15, 0800/1300

LOCATION: Hilton, 620 Perry Pkwy., Gaithersburg, Md.

CONTACT: Bryan Emery or Pearline Muckelvene, 301-827-0314

On Dec. 14, the committee will discuss the risk of dengue
virus infection in blood donors as well as murine leukemia
virus-related human retroviruses and blood safety.

On Dec. 15, the committee will hear updates on:

* the November meeting of the Health and Human Services
Advisory Committee on Blood Safety and Availability

* the December FDA workshop on “Product Development Program
for Interventions in Patients With Severe Bleeding Due to
Trauma and Other Causes”

* Research programs in the Laboratories of Hemostasis and
Plasma Derivatives, Division of Hematology, Office of Blood
Research and Review, Center for Biologics Evaluation and
Research.

NEUROLOGICAL DEVICES PANEL OF THE MEDICAL DEVICES ADVISORY
COMMITTEE

DATE: Jan. 27-28, 2011, beginning at 0800/1300

LOCATION: Hilton, 620 Perry Pkwy., Gaithersburg, Md.

CONTACT: James Engles, 301-796-7543

The committee will discuss and make recommendations
regarding the possible reclassification of devices indicated
for use in electroconvulsive therapy.
(Reporting by Lisa Richwine and Susan Heavey; Editing by Tim
Dobbyn)

U.S. FDA advisory meetings through Jan 28